Inovio Pharmaceuticals is trading at $0.90, up 7.00%, as the cause of the October 23 gain remains unclear.

  • A $80,416,101 court judgment was announced October 20, but defendants’ financial condition may limit collection; the judgment does not clearly explain the gain.
  • The biotech sector and major indexes are lower, so broader market conditions do not account for the rise.